Diligent Pharma

Diligent Pharma is a quality and compliance organization for the clinical trial industry that connects trial Sponsors and Vendors on a single, secure platform. Its core message is “Simplify Vendor discovery, qualification, & oversight”: help drug developers mitigate risk, raise quality, and shorten trial start-up timelines by managing every outsourced partner, such as CROs and other service providers, in one centralized system.

For Sponsors, the flagship product is Diligent360, a platform that combines a searchable industry-wide database of clinical Vendors, a regulation-based library of questionnaires and audit reports, subject-matter-expert risk scoring, and centralized oversight of compliance data and requalification schedules. The company says this brings qualification timelines down from months to days, and cites results of three to five months shaved off timelines and more than 31,000 audit hours saved for clients since 2021.

Vendors get their own tools. DiligentQualified lets a Vendor host a single independent qualification audit per year and release the report to any client, while DiligentRespond automates questionnaire and RFI responses so teams can complete them faster with fewer resources. Vendors can also be listed in the VendorBase to reach Sponsors actively looking for partners.

Beyond software, Diligent offers expertise in GxP audit services, global regulatory coverage with an ICH-aligned approach, and risk domains such as cybersecurity and AI. Its solutions are tailored to teams in clinical operations, procurement and sourcing, quality, and business development, with a dedicated offer for biotechs. Clients and partners shown on the site include Novotech, Syndax, and Kailera, and the company shares thought leadership through webinars, customer stories, a blog, and a podcast, including an upcoming session on vendor qualification under ICH E6(R3).